MEDICAMEN BIOTECH
Back to Cashflow Statement
|
MEDICAMEN BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹-6.74 Cr | ₹-6.29 Cr | ₹4.11 Cr | ₹13 Cr | ₹13 Cr |
What is the latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹-6.74 Cr |
Mar2023 | ₹-6.29 Cr |
Mar2022 | ₹4.11 Cr |
Mar2021 | ₹13 Cr |
Mar2020 | ₹13 Cr |
How is Cash Flow from Operating Activities of MEDICAMEN BIOTECH Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-6.74 Cr | Negative | |
Mar2023 | ₹-6.29 Cr | Negative | |
Mar2022 | ₹4.11 Cr | -67.83 | |
Mar2021 | ₹13 Cr | -0.23 | |
Mar2020 | ₹13 Cr | - |
Compare Cash Flow from Operating Activities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹650.5 Cr | 9.3% | 6.8% | 1.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | 9.3% |
6.8% |
1.1% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses